Navigation Links
New Rheumatoid Arthritis Treatment

A new study shows a novel new drug is beneficial for patients with rheumatoid arthritis. The drug targets T cells and is the first in a new class of drugs to be tested for rheumatoid arthritis. //

The drug is called cytotoxic T-lymphocyte-associated antigen 4-IgG1 or CTLA4Ig. Preliminary research shows CTLA4Ig may be effective for the treatment of rheumatoid arthritis. Researchers from Belgium conducted a study to see if this drug is helpful for patients with rheumatoid arthritis.

Rheumatoid arthritis is a disease that causes progressive joint damage and disability. For the study, researchers assigned patients to receive one of two doses of CTLA4Ig or placebo. All of the patients also received methotrexate therapy during the study. Researchers assessed the patients after six months using the criteria of the American College of Rheumatology (ACR). The ACR defines the response to the treatment according to its extent. A 20 percent clinical response rate is noted as ACR 20, 50 percent is ACR 50, and 70 percent is ACR 70. Researchers also looked at the patients’ quality of life.

Researchers report the patients treated with the higher dose of CTLA4Ig were more likely to have an ACR 20 than patients who received placebo. Higher rates of ACR 50 and ACR 70 were seen in both groups on the drug compared to placebo. The patients on the higher dose of the drug also saw improvements in eight measures of quality of life.

Study authors conclude the combination of CTLA4Ig and methotrexate improved the signs and symptoms of the disease, physical function, and quality of life in patients with rheumatoid arthritis. Researchers also say both doses of the drug were well tolerated by the patients. They say this study shows the value of this new class of drugs in the treatment of rheumatoid arthritis
'"/>




Page: 1

Related medicine news :

1. New treatment for Rheumatoid Arthritis
2. New Rheumatoid Arthritis Treatment
3. Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis
4. The Link Between Rheumatoid Arthritis And Heart Failure
5. Smoking during pregnancy increases risk of Rheumatoid Arthritis.
6. Good News For Those Of You Suffering From Rheumatoid Arthritis
7. Mineral Oil exposure increases risk of Rheumatoid Arthritis
8. Mineral Oil exposure increases risk of Rheumatoid Arthritis
9. Novel drug holds promise for treatment of Rheumatoid Arthritis
10. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
11. Protein Linked To Accelerating Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... Chicago, Illinois (PRWEB) , ... May 05, 2016 ... ... published its “deeming regulations” for electronic cigarettes, requiring e-cigarette manufacturers to submit ... as a “tobacco product,” apply to all vaping products that entered the market ...
(Date:5/5/2016)... ... May 05, 2016 , ... TLC Laser Eye Centers announced today that ... eye center will now be called “Gordon Schanzlin New Vision Institute, a TLC Laser ... the full-service facility to ensure that patients continue to receive the highest quality of ...
(Date:5/5/2016)... ... 2016 , ... Phycologia – While it is ... researchers Juntian Xu and Kunshan Gao tested the magnitude of this phenomenon on ... photosynthetically active radiation (i.e. the white light in our visible spectrum) was not ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... organization, announces McLaughlin & Smoak Benefits as the latest addition to its family ... has a dedicated team of compliance, wellness, human resources, and health care consumerism ...
(Date:5/5/2016)... ... May 05, 2016 , ... An essential tool for researching ... certain Canadian provinces is now available from the International Association of Industrial Accident ... The report, Workers’ Compensation Laws as of January 1, 2016, is ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Calif. , May 5, 2016  Diagnostic ... a decade due to concerns that these tests ... the approach to imaging, as well as the ... new era of medical peripherals that help health care providers ...   Ampronix  advanced medical imaging is a renowned authorized ...
(Date:5/5/2016)... May 5, 2016 Research and Markets has ... in Top 5 EU Markets"  report to their offering.  ,     ... provides information on the current Positron Emission Tomography (PET) scanner ... (T5 EU), which includes France , ... Spain and the United Kingdom ...
(Date:5/5/2016)... , May 5, 2016 /PRNewswire/ ... announced the addition of the  "Europe ... - 2016"  report to their offering.  ... ) , ,The latest research ... Highlights - 2016, provides comprehensive insights ...
Breaking Medicine Technology: